Shanghai Pharmaceuticals' Subsidiary Receives Generic Drug Consistency Evaluation Approval for Lincomycin Hydrochloride Injection

Stock News09-10

Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH) has announced that its subsidiary, Shanghai Hefeng Pharmaceutical Co., Ltd., recently received the Drug Supplement Approval Notice from the National Medical Products Administration for lincomycin hydrochloride injection, confirming that the product has passed the generic drug consistency evaluation.

The medication is indicated for treating severe infections caused by susceptible strains such as streptococci, pneumococci, and staphylococci. However, it should only be used in patients who are allergic to penicillin or in cases where a physician determines that penicillin therapy is not appropriate.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1189932678?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-09-10 18:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189932678","market":"nz","top_or_hot":-1,"title":"Shanghai Pharmaceuticals' Subsidiary Receives Generic Drug Consistency Evaluation Approval for Lincomycin Hydrochloride Injection","media":"Stock News","content":"<p><b>Shanghai Pharmaceuticals Holding Co., Ltd.</b> (601607.SH) has announced that its subsidiary, Shanghai Hefeng Pharmaceutical Co., Ltd., recently received the Drug Supplement Approval Notice from the National Medical Products Administration for lincomycin hydrochloride injection, confirming that the product has passed the generic drug consistency evaluation.<br><br>The medication is indicated for treating severe infections caused by susceptible strains such as streptococci, pneumococci, and staphylococci. However, it should only be used in patients who are allergic to penicillin or in cases where a physician determines that penicillin therapy is not appropriate.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Pharmaceuticals' Subsidiary Receives Generic Drug Consistency Evaluation Approval for Lincomycin Hydrochloride Injection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Pharmaceuticals' Subsidiary Receives Generic Drug Consistency Evaluation Approval for Lincomycin Hydrochloride Injection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-09-10 18:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Shanghai Pharmaceuticals Holding Co., Ltd.</b> (601607.SH) has announced that its subsidiary, Shanghai Hefeng Pharmaceutical Co., Ltd., recently received the Drug Supplement Approval Notice from the National Medical Products Administration for lincomycin hydrochloride injection, confirming that the product has passed the generic drug consistency evaluation.<br><br>The medication is indicated for treating severe infections caused by susceptible strains such as streptococci, pneumococci, and staphylococci. However, it should only be used in patients who are allergic to penicillin or in cases where a physician determines that penicillin therapy is not appropriate.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0020","symbol_name":"浦东新区","start_time":0,"source_url":"","article_id":"1189932678","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189932678","pubTimestamp":1789037778,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH) has announced that its subsidiary, Shanghai Hefeng Pharmaceutical Co., Ltd., recently received the Drug Supplement Approval Notice from the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"601607":"上海医药","BK0020":"浦东新区","BK1197":"保健护理产品经销商","BK0183":"MSCI概念","BK0012":"证金概念","BK0097":"医药电商","BK0099":"上海本地重组","BK0188":"融资融券","BK0175":"白马股","BK0209":"零售","02607":"上海医药","BK0196":"行业龙头","BK0187":"一线龙头","BK0184":"上海国资改革","BK0028":"国家队"},"translate_title":"上海医药子公司盐酸林可霉素注射液获仿制药一致性评价批件","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"601607":1,"02607":1},"content_text":"Shanghai Pharmaceuticals Holding Co., Ltd. (601607.SH) has announced that its subsidiary, Shanghai Hefeng Pharmaceutical Co., Ltd., recently received the Drug Supplement Approval Notice from the National Medical Products Administration for lincomycin hydrochloride injection, confirming that the product has passed the generic drug consistency evaluation.The medication is indicated for treating severe infections caused by susceptible strains such as streptococci, pneumococci, and staphylococci. However, it should only be used in patients who are allergic to penicillin or in cases where a physician determines that penicillin therapy is not appropriate.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1189932678","isCrawlerRequest":true}